Carnesecchi et al., 2004; Vieira et al., 2011
|
Geraniol |
5-FU |
Caco-2 cell line |
Synergistic: 20% reduction in cell survival |
Down-regulation of Bcl-2 |
Carnesecchi et al., 2004
|
Geraniol |
5-FU |
Mice xenograft (TC118) |
Synergistic: 80% reduction in tumor size |
Unknown |
Serova et al., 2006
|
Irofulven |
Oxaliplatin |
HT-29 cell line |
Synergistic: reduced cell survival |
Unknown |
Britten et al., 1999
|
Irofulven |
Irinotecan |
Mice xenograft (HT-29) |
Synergistic: tumor size reduction |
Unknown |
Liu et al., 2011
|
Artesunate |
Oxaliplatin |
HCT116 cell line |
Synergistic: 50% cell killing |
ROS induction |
Liu et al., 2014
|
Triptolide |
Oxaliplatin |
SW480 cell line |
Synergistic: 62% cell killing |
Apoptosis induction, blocking of β-catenin translocation to nucleus |
Liu et al., 2014
|
Triptolide |
Oxaliplatin |
Mice xenograft (SW480) |
Synergistic: 60% tumor growth reduction |
Unknown |
Koh et al., 2012; Prasad et al., 2012
|
Ursolic acid |
Radiotherapy |
CT26 and HCT116 cell lines |
Synergistic: 55% cell killing |
Apoptosis induction, caspase 3 activation, ROS increase, GSH, NF-kB and Bcl-2 reductions |
Wang et al., 2015
|
Ginsenolides |
5-FU |
Mice xenograft (HCT116) |
Synergistic: reduced tumor size |
G1 arrest |
Kim et al., 2009
|
Ginsenolides |
Docetaxel |
HCT116 cell line |
Synergistic: increased cell death |
NF-kB inhibiton, Bcl-2 repression |
Zhu et al., 2010
|
Calastrol |
TRAIL |
SW620 cell line |
Synergistic: increased cell killing |
Apoptosis induction |
Jung et al., 2007
|
Betulinic acid |
5-FU, oxaliplatin, irinotecan |
SNU-C5 cell line |
Synergistic: increased cell killing, reduction in chemoresistance |
Apoptosis induction (caspase 3) |
Li et al., 2007
|
Curcumin |
Oxaliplatin |
Lo-Vo cell line |
Synergistic: growth inhibition |
Unknown |
Anitha et al., 2014
|
Curcumin |
5-FU |
HT-29 |
Synergistic: increased cells killing |
Apoptosis induction |
Murakami et al., 2013
|
Curcumin |
Turmerones |
CRC mouse model (dimethyl-hydrazine) |
Synergistic: tumor size reduction |
Apoptosis induction |
Yue et al., 2016b
|
Curcumin |
Bevacizumab |
Mice xenograft (HT-29) |
Synergistic: tumor size reduction |
Apoptosis induction |
Zhang et al., 2003; Lan et al., 2015
|
Gossypol |
5-FU |
Mice xenograft (HT-29) |
Synergistic: tumor size reduction |
Apoptosis induction, chemical sensitization |